These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 16865086)

  • 1. Use of recombinant activated factor VII (rFVIIa-NovoSeven) in the treatment of uncontrolled postsurgical hemorrhage in a patient with deep venous thrombosis and caval filter. A case report.
    Marson F; Farnia A; Callegher L; Casagrande L; Surdu M; Sarpellon M
    Minerva Anestesiol; 2006; 72(7-8):675-82. PubMed ID: 16865086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
    Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K
    Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease.
    Razon Y; Erez E; Vidne B; Birk E; Katz J; Tamari H; Dagan O
    Paediatr Anaesth; 2005 Mar; 15(3):235-40. PubMed ID: 15725322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage.
    Brady KM; Easley RB; Tobias JD
    Paediatr Anaesth; 2006 Oct; 16(10):1042-6. PubMed ID: 16972833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry.
    Dunkley S; Phillips L; McCall P; Brereton J; Lindeman R; Jankelowitz G; Cameron P
    Ann Thorac Surg; 2008 Mar; 85(3):836-44. PubMed ID: 18291152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of recombinant activated Factor VII for refractory after lung transplant bleeding as an effective strategy to restrict blood transfusion and associated complications.
    Bhaskar B; Zeigenfuss M; Choudhary J; Fraser JF
    Transfusion; 2013 Apr; 53(4):798-804. PubMed ID: 22845023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant activated Factor VII as a hemostatic agent in very low birth weight preterms with gastrointestinal hemorrhage and disseminated intravascular coagulation.
    Fischer D; Schloesser R; Buxmann H; Veldman A
    J Pediatr Hematol Oncol; 2008 May; 30(5):337-42. PubMed ID: 18458565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of gastrointestinal bleeding with recombinant factor VIIa after kidney transplantation in patients with pancytopenia.
    Malato A; Lo Monte AI; Anastasio R; Lo Coco L; Abbene I; Maione C; Gioviale MC; Siragusa S
    Transplant Proc; 2006 May; 38(4):1031-3. PubMed ID: 16757254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant activated factor VII: treating postoperative hemorrhage in cardiac surgery.
    Bishop CV; Renwick WE; Hogan C; Haeusler M; Tuckfield A; Tatoulis J
    Ann Thorac Surg; 2006 Mar; 81(3):875-9. PubMed ID: 16488687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of using recombinant factor VIIa in continuous infusion.
    Schulman S; Bech Jensen M; Varon D; Keller N; Gitel S; Horoszowski H; Heim M; Martinowitz U
    Thromb Haemost; 1996 Mar; 75(3):432-6. PubMed ID: 8701403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery.
    Agarwal HS; Bennett JE; Churchwell KB; Christian KG; Drinkwater DC; He Y; Taylor MB
    Ann Thorac Surg; 2007 Jul; 84(1):161-8. PubMed ID: 17588404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment using recombinant factor VIIa for severe bleeding post cardiopulmonary bypass.
    Naik VN; Mazer CD; Latter DA; Teitel JM; Hare GM
    Can J Anaesth; 2003; 50(6):599-602. PubMed ID: 12826554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant factor VIIa reduces bleeding risk in patients on platelet aggregation inhibitors immediately prior to renal transplantation--a retrospective analysis.
    Loertzer H; Soukup J; Fornara P
    Urol Int; 2007; 78(2):135-9. PubMed ID: 17293653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant activated factor VII use in critically ill infants with active hemorrhage.
    Jen H; Shew S
    J Pediatr Surg; 2008 Dec; 43(12):2235-8. PubMed ID: 19040942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of bleeding in severe hemorrhagic pancreatitis with recombinant factor VIIa.
    Schuster R; Lee SJ; Rink D
    Am Surg; 2003 Nov; 69(11):1017-8. PubMed ID: 14627269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment with recombinant factor VIIa for intractable bleeding at pelvic surgery.
    Daniloś J; Goral A; Paluszkiewicz P; Przesmycki K; Kotarski J
    Obstet Gynecol; 2003 Jun; 101(6):1172-3. PubMed ID: 12798520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of recombinant activated factor VII concentrate to control postoperative hemorrhage in complex cardiovascular surgery.
    Bowman LJ; Uber WE; Stroud MR; Christiansen LR; Lazarchick J; Crumbley AJ; Kratz JM; Toole JM; Crawford FA; Ikonomidis JS
    Ann Thorac Surg; 2008 May; 85(5):1669-76; discussion 1676-7. PubMed ID: 18442563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of recombinant activated Factor VII in patients with massive uncontrolled bleeding: a retrospective observational analysis.
    Berkhof FF; Eikenboom JC
    Transfusion; 2009 Mar; 49(3):570-7. PubMed ID: 19040498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful management of bleeding with recombinant factor VIIa (NovoSeven) in a patient with Burkitt lymphoma and thrombosis of the left femoral and left common iliac veins.
    Culić S; Kuljis D; Armanda V; Jankovic S
    Pediatr Blood Cancer; 2007 Sep; 49(3):332-5. PubMed ID: 16514611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraoperative use of recombinant activated factor VII (rFVIIa).
    De Gasperi A
    Minerva Anestesiol; 2006 Jun; 72(6):489-94. PubMed ID: 16682921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.